CD34 and acute myeloid leukemia: We also confirmed that miR-126 is highly expressed in t(8;21) AML CD34+ cells, and miRisten treatment similarly increased apoptosis and reduced quiescence of t(8;21) AML CD34+ cells (Supplementary Fig. 10).